Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors JF Shern, L Chen, J Chmielecki, JS Wei, R Patidar, M Rosenberg, ... Cancer discovery 4 (2), 216-231, 2014 | 745 | 2014 |
The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias AK Andersson, J Ma, J Wang, X Chen, AL Gedman, J Dang, J Nakitandwe, ... Nature genetics 47 (4), 330-337, 2015 | 506 | 2015 |
The genomic landscape of the Ewing sarcoma family of tumors reveals recurrent STAG2 mutation A Brohl, D Solomon, W Chang, J Wang, Y Song, S Sandiri, R Patidar, ... PLoS Genetics 10 (7), e1004475, 2014 | 448 | 2014 |
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models JGT Vi, AT Cheuk, PS Tsang, JY Chung, YK Song, K Desai, Y Yu, ... The Journal of clinical investigation 119 (11), 3395-3407, 2009 | 370 | 2009 |
The genetic basis and cell of origin of mixed phenotype acute leukaemia TB Alexander, Z Gu, I Iacobucci, K Dickerson, JK Choi, B Xu, ... Nature 562 (7727), 373-379, 2018 | 318 | 2018 |
Relational autoencoder for feature extraction Q Meng, D Catchpoole, D Skillicom, PJ Kennedy 2017 International joint conference on neural networks (IJCNN), 364-371, 2017 | 296 | 2017 |
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma JS Wei, BT Greer, F Westermann, SM Steinberg, CG Son, QR Chen, ... Cancer research 64 (19), 6883-6891, 2004 | 258 | 2004 |
Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors J Torchia, B Golbourn, S Feng, KC Ho, P Sin-Chan, A Vasiljevic, ... Cancer cell 30 (6), 891-908, 2016 | 249 | 2016 |
Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour D Astuti, F Latif, K Wagner, D Gentle, WN Cooper, D Catchpoole, ... British journal of cancer 92 (8), 1574-1580, 2005 | 164 | 2005 |
Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway KW Brown, AJ Villar, W Bickmore, J Clayton-Smith, D Catchpoole, ... Human molecular genetics 5 (12), 2027-2032, 1996 | 154 | 1996 |
Epigenetic analysis of childhood acute lymphoblastic leukemia TL Dunwell, LB Hesson, TV Pavlova, V Zabarovska, VI Kashuba, ... Epigenetics 4 (3), 185-193, 2009 | 153 | 2009 |
Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome JA Joyce, WK Lam, DJ Catchpoole, P Jenks, W Reik, ER Maher, ... Human molecular genetics 6 (9), 1543-1548, 1997 | 150 | 1997 |
High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma RL Stallings, P Nair, JM Maris, D Catchpoole, M McDermott, A O'Meara, ... Cancer research 66 (7), 3673-3680, 2006 | 141 | 2006 |
A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers T Dunwell, L Hesson, TA Rauch, L Wang, RE Clark, A Dallol, D Gentle, ... Molecular cancer 9, 1-12, 2010 | 130 | 2010 |
Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis CC Whiteford, S Bilke, BT Greer, Q Chen, TA Braunschweig, N Cenacchi, ... Cancer research 67 (1), 32-40, 2007 | 130 | 2007 |
The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias LB Hesson, TL Dunwell, WN Cooper, D Catchpoole, AT Brini, ... Molecular cancer 8, 1-10, 2009 | 128 | 2009 |
Epigenetic modification and uniparental inheritance of H19 in Beckwith-Wiedemann syndrome. D Catchpoole, WW Lam, D Valler, IK Temple, JA Joyce, W Reik, ... Journal of medical genetics 34 (5), 353-359, 1997 | 115 | 1997 |
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma QR Chen, S Bilke, JS Wei, CC Whiteford, N Cenacchi, AL Krasnoselsky, ... BMC genomics 5, 1-13, 2004 | 114 | 2004 |
Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma JS Wei, IB Kuznetsov, S Zhang, YK Song, S Asgharzadeh, S Sindiri, ... Clinical Cancer Research 24 (22), 5673-5684, 2018 | 110 | 2018 |
Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death DR Catchpoole, BW Stewart cancer research 53 (18), 4287-4296, 1993 | 105 | 1993 |